USPlus DERM
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for USPlus DERM, covering 2025-04-10 to 2025-04-10. Get the full timeline:
Most recent: Clinical Trial Update: A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair. [NA]